Blocks in the catabolism of sulphatides and gangliosides as a cause of human neurological diseases.
作者信息
Jatzkewitz H, Mehl E, Sandhoff K
出版信息
Biochem J. 1970 Apr;117(2):6P-8P. doi: 10.1042/bj1170006p.
Abstract
摘要
相似文献
1
Blocks in the catabolism of sulphatides and gangliosides as a cause of human neurological diseases.硫脂和神经节苷脂分解代谢受阻作为人类神经疾病的一个病因
Biochem J. 1970 Apr;117(2):6P-8P. doi: 10.1042/bj1170006p.
2
Metabolic disorders of sphingolipid metabolism in man.人类鞘脂代谢的代谢紊乱。
Chem Phys Lipids. 1970 Oct;5(1):261-9. doi: 10.1016/0009-3084(70)90023-x.
3
[Neurolipidoses and nervous system diseases with lipid metabolism disorders].
Cas Lek Cesk. 1972;111(8):182-4.
4
5
[Leukodystrophy, Scholz' type, (metachromatic form of diffuse sclerosis) with sphinolipoidosis (cerebroside-sulfuric acid ester storage disease)].[舒尔茨型脑白质营养不良（弥漫性硬化的异染性形式）伴鞘脂沉积症（脑苷脂 - 硫酸酯贮积病）]
Hoppe Seylers Z Physiol Chem. 1960 May 31;318:265-77. doi: 10.1515/bchm2.1960.318.1.265.
6
Biochemical and metabolic basis of familial sphingolipidoses.家族性鞘脂贮积症的生化与代谢基础
Semin Hematol. 1972 Jul;9(3):273-84.
7
The problem of coexistence of neuronal lipid storage diseases and various forms of leucocystrophies.神经元脂质贮积病与各种形式脑白质营养不良并存的问题。
Neuropatol Pol. 1971;9(3):201-9.
8
Degenerative disease of the central nervous system.中枢神经系统退行性疾病
Adv Pediatr. 1969;16:121-75.
9
[Lipoidosis--with special reference to metachromatic leucodystrophy and Tay-Sachs disease].
Nihon Rinsho. 1967 Oct;25(8):1597-606.
10
Fatty acid composition of cholesterol esters in brains of patients with Schilder's disease, G M1 -gangliosidosis and Tay-Sachs disease, and its possible relationship to the -position fatty acids of lecithin.希尔德病、GM1神经节苷脂病和泰-萨克斯病患者大脑中胆固醇酯的脂肪酸组成及其与卵磷脂ω位脂肪酸的可能关系。
J Neurochem. 1971 Jun;18(6):1007-16. doi: 10.1111/j.1471-4159.1971.tb12030.x.
引用本文的文献
1
Histochemical localization of the soluble arylsulphatase activities in rat brain.大鼠脑中可溶性芳基硫酸酯酶活性的组织化学定位
Histochemie. 1971;24(3):251-65. doi: 10.1007/BF00304195.
本文引用的文献
1
[Leukodystrophy, Scholz' type, (metachromatic form of diffuse sclerosis) with sphinolipoidosis (cerebroside-sulfuric acid ester storage disease)].[舒尔茨型脑白质营养不良（弥漫性硬化的异染性形式）伴鞘脂沉积症（脑苷脂 - 硫酸酯贮积病）]
Hoppe Seylers Z Physiol Chem. 1960 May 31;318:265-77. doi: 10.1515/bchm2.1960.318.1.265.
2
METABOLISM OF GLUCOCEREBROSIDES. II. EVIDENCE OF AN ENZYMATIC DEFICIENCY IN GAUCHER'S DISEASE.葡萄糖脑苷脂的代谢。II. 戈谢病中酶缺乏的证据。
Biochem Biophys Res Commun. 1965 Jan 18;18:221-5. doi: 10.1016/0006-291x(65)90743-6.
3
A CONTROLLED STUDY OF ENZYMIC ACTIVITIES IN THREE HUMAN DISORDERS OF GLYCOLIPID METABOLISM.三项人类糖脂代谢紊乱中酶活性的对照研究。
J Neurochem. 1963 Dec;10:805-16. doi: 10.1111/j.1471-4159.1963.tb11905.x.
4
The chemical structure of normal human brain and Tay-Sachs gangliosides.正常人脑和泰-萨克斯神经节苷脂的化学结构。
Biochem Biophys Res Commun. 1962 Nov 27;9:436-41. doi: 10.1016/0006-291x(62)90030-x.
5
[Two types of cerebroside sulfates as so-called prelipids and storage substances in leukodystrophy of type Scholz (metachromatic form of diffuse sclerosis)].[两种脑硫脂作为所谓的前脂和施尔茨型脑白质营养不良（弥漫性硬化的异染性形式）中的储存物质]
Hoppe Seylers Z Physiol Chem. 1958;311(4-6):279-82.
6
Variation of beta-N-acetylhexosaminidase-pattern in Tay-Sachs disease.泰-萨克斯病中β-N-乙酰己糖胺酶模式的变化。
FEBS Lett. 1969 Aug;4(4):351-354. doi: 10.1016/0014-5793(69)80274-7.
7
Enzymatic hydrolysis of sphingolipids. V. Hydrolysis of monosialoganglioside and hexosylceramides by rat brain beta-galactosidase.鞘脂的酶促水解。V. 大鼠脑β-半乳糖苷酶对单唾液酸神经节苷脂和己糖神经酰胺的水解作用
Biochim Biophys Acta. 1967 Feb 14;137(1):192-5. doi: 10.1016/0005-2760(67)90027-6.
8
Metabolism of sulfatides. I. The effect of galactocerebrosides on the synthesis of sulfatides.
Biochem Biophys Res Commun. 1965 Jul 12;20(2):109-13. doi: 10.1016/0006-291x(65)90331-1.
9
[A cerebrosidesulfatase from swine kidney].[来自猪肾的脑硫脂硫酸酯酶]
Hoppe Seylers Z Physiol Chem. 1964;339(1):260-76.
10
Tay-Sachs disease: generalized absence of a beta-D-N-acetylhexosaminidase component.泰-萨克斯病：普遍缺乏β-D-N-乙酰己糖胺酶成分。
Science. 1969 Aug 15;165(3894):698-700. doi: 10.1126/science.165.3894.698.
Zotero 插件